Conference News

June 10, 2026

COPD Severity Tied to Life Expectancy

A pooled US cohort study estimated years of life lost across airflow obstruction severity, including among adults who never smoked.

Conexiant

June 05, 2026

Sleep Study Cutoffs May Guide Discharge

Preoperative sleep study values may distinguish lower-risk children within a population for whom overnight admission is currently routine.

Conexiant

June 05, 2026

Can Finerenone Alter Glomerular Disease Trajectory?

A prespecified exploratory analysis of the FIND-CKD clinical trial examined kidney function, albuminuria, and kidney failure outcomes in 903 patients with glomerular diseases.

Conexiant

May 29, 2026

FDA Expands Afrezza to Pediatric Diabetes

The decision was supported by the phase 3 INHALE-1 trial and additional long-term safety, efficacy, and exposure data.

Conexiant

May 29, 2026

FDA Monthly Preview: Key June Decisions to Watch

Several FDA decisions across multiple specialties are expected this month.

Conexiant

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.

May 13, 2026

PCOS Renamed PMOS After Global Consensus

International initiative reframes a common endocrine disorder around its metabolic and ovarian features rather than ovarian cysts

Conexiant

May 12, 2026

Digitalis Reduces HF Events but Not Mortality

Meta-analysis of randomized trials found fewer worsening heart failure events among patients with reduced or mildly reduced ejection fraction.

Conexiant

April 29, 2026

FDA Monthly Preview: Key May Decisions to Watch

Several FDA decisions across multiple specialties are expected this month.

Conexiant

April 28, 2026

This Week’s Biopharma News: Wave of Antibody Approvals

FDA expands Tzield, EU clears Dupixent, and Health Canada approves denosumab antibody biosimilars

The Medicine Maker

April 17, 2026

Radiology Groups Push Back on New Cancer Screening Guidelines

Radiology groups say the ACP's new screening recommendations conflict with nearly every major cancer organization and could cost thousands of lives annually.

Conexiant

Oral HRS-7535 Lowered A1c in Trial

Conference News

COPD Severity Tied to Life Expectancy

Sleep Study Cutoffs May Guide Discharge

Can Finerenone Alter Glomerular Disease Trajectory?

FDA Expands Afrezza to Pediatric Diabetes

FDA Monthly Preview: Key June Decisions to Watch

Daily News

PCOS Renamed PMOS After Global Consensus

Digitalis Reduces HF Events but Not Mortality

FDA Monthly Preview: Key May Decisions to Watch

This Week’s Biopharma News: Wave of Antibody Approvals

Radiology Groups Push Back on New Cancer Screening Guidelines

Recommendations

Surgical Techniques to Remove Subretinal Perfluoro-n-Octane

Surgical Techniques to Remove Subretinal Perfluoro-n-Octane

Surgical Techniques to Remove Subretinal Perfluoro-n-Octane

Surgical Techniques to Remove Subretinal Perfluoro-n-Octane

Trending Now

Oral HRS-7535 Lowered A1c in Trial

Trending Now

Find topic & conditions by first letter

Compendium

Inside Dental Hygiene

Inside Dentistry

ADA News

CDE World

New Dentist News

The ASCO Post

JADPRO

JNCCN

JNCCN 360

ASCO AI in Oncology

Glaucoma Physician

Ophthalmology Management

Retinal Physician

The Ophthalmologist

Contact Lens Spectrum

Eyecare Business

Optometric Management

The Pathologist

Conference News

Daily News

Recommendations